Comparing COVID-19 vaccination coverage, adverse reactions and impact of social determinants of health on vaccine hesitancy in ADRD/MCI and non-ADRD/MCI population: protocol for a retrospective cross-sectional study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
    • Subject Terms:
      COVID-19*/prevention & control ; COVID-19*/epidemiology ; COVID-19*/psychology ; Vaccination Hesitancy*/psychology ; Vaccination Hesitancy*/statistics & numerical data ; Social Determinants of Health* ; COVID-19 Vaccines*/adverse effects ; COVID-19 Vaccines*/administration & dosage; Humans ; Cross-Sectional Studies ; Retrospective Studies ; SARS-CoV-2 ; Vaccination Coverage/statistics & numerical data ; Cognitive Dysfunction/prevention & control ; Alzheimer Disease/psychology ; Dementia/psychology ; Research Design ; Male ; Female
    • Abstract:
      Introduction: COVID-19 vaccination is crucial for vulnerable people with underlying chronic conditions such as Alzheimer's disease and related dementias (ADRD) and mild cognitive impairment (MCI). These individuals face unique challenges, including higher risk of COVID-19, difficulties in adopting preventive behaviours and vaccine hesitancy due to concerns about adverse reactions. Therefore, efforts to promote vaccination, including boosters tailored to the currently circulating virus, are essential for people with ADRD/MCI.
      Objective: The primary purpose of this study protocol is to conduct a comprehensive analysis of COVID-19 vaccination coverage and adverse reactions among individuals with ADRD/MCI in comparison to those without ADRD/MCI. Additionally, the proposed study aims to investigate the impact of social determinants of health on COVID-19 vaccination and vaccine hesitancy in individuals with ADRD/MCI.
      Methods and Analysis: A retrospective cross-sectional study will be conducted utilising data from the All of Us (AoU ) Researcher Workbench. Relevant data fields are extracted from sources including demographic information, COVID-19 Vaccine Survey, Basic Survey, Health Access & Utilization, Social Determinants of Health, and Electronic Health Record (EHR) data. Data on vaccination, adverse reactions and vaccine hesitancy will be collected through COVID-19 vaccine survey questionnaires. Propensity score matching and binary logistic regression will be applied to assess the vaccination rates and vaccine hesitancy, while controlling for demographic characteristics and social determinants of health factors.
      Ethics and Dissemination: This study protocol received approval from the Institutional Review Board at Florida State University (STUDY00004571). Results will be disseminated through publication in peer-reviewed journals and presented at scientific conferences.
      Competing Interests: Competing interests: None declared.
      (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
    • References:
      JAMA Neurol. 2023 Sep 1;80(9):919-928. (PMID: 37459088)
      Clin Geriatr Med. 2022 Aug;38(3):501-517. (PMID: 35868669)
      Vaccine. 2021 Jul 13;39(31):4245-4249. (PMID: 34167838)
      Geroscience. 2024 Jun;46(3):2885-2899. (PMID: 38393535)
      QJM. 2021 Nov 5;114(8):543-547. (PMID: 33453109)
      Front Psychiatry. 2021 Dec 16;12:805528. (PMID: 34975599)
      Alzheimers Dement. 2023 Feb;19(2):421-432. (PMID: 35417628)
      Alzheimers Dement. 2024 May;20(5):3708-3821. (PMID: 38689398)
      N Engl J Med. 2021 Apr 15;384(15):1412-1423. (PMID: 33626250)
      EClinicalMedicine. 2020 Sep;26:100495. (PMID: 32838242)
      BMJ. 2023 Mar 1;380:491. (PMID: 36858426)
      Front Public Health. 2023 Jun 27;11:1172642. (PMID: 37441645)
      Ann Epidemiol. 2024 Apr;92:17-24. (PMID: 38382771)
      J Alzheimers Dis. 2022;87(1):415-432. (PMID: 35311707)
      Medicina (Kaunas). 2021 Oct 25;57(11):. (PMID: 34833377)
      J Community Health. 2021 Apr;46(2):270-277. (PMID: 33389421)
      Psychol Methods. 2003 Sep;8(3):305-21. (PMID: 14596493)
      N Engl J Med. 2021 Feb 4;384(5):403-416. (PMID: 33378609)
      Lancet. 2020 Aug 8;396(10248):413-446. (PMID: 32738937)
      Multivariate Behav Res. 2011 May;46(3):399-424. (PMID: 21818162)
      JAMA Netw Open. 2020 Oct 1;3(10):e2025594. (PMID: 33079199)
      Lancet Respir Med. 2024 May;12(5):e33-e34. (PMID: 38614106)
      Front Public Health. 2023 Oct 02;11:1281266. (PMID: 37849724)
      J Public Health (Oxf). 2023 Mar 14;45(1):e65-e74. (PMID: 34994801)
      BMJ Open. 2023 May 15;13(5):e070869. (PMID: 37188476)
      Aging Clin Exp Res. 2022 Feb;34(2):309-324. (PMID: 34319511)
      N Engl J Med. 2019 Aug 15;381(7):668-676. (PMID: 31412182)
      Alzheimers Dement. 2022 May;18(5):911-923. (PMID: 35377523)
      Annu Int Conf IEEE Eng Med Biol Soc. 2022 Jul;2022:1354-1357. (PMID: 36086543)
      JAMA. 2022 Jul 5;328(1):10. (PMID: 35788805)
      N Engl J Med. 2020 Dec 31;383(27):2603-2615. (PMID: 33301246)
    • Contributed Indexing:
      Keywords: COVID-19; Chronic Disease; Dementia; GERIATRIC MEDICINE; PUBLIC HEALTH
    • Accession Number:
      0 (COVID-19 Vaccines)
    • Publication Date:
      Date Created: 20240716 Date Completed: 20240716 Latest Revision: 20240719
    • Publication Date:
      20240719
    • Accession Number:
      PMC11253747
    • Accession Number:
      10.1136/bmjopen-2023-082988
    • Accession Number:
      39013656